Delivery Order SPE2DB22D9112-SPE2DB25FTKKH

Award Date 3/6/25
Potential Completion Date 3/7/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of JAKAFI 10 MG TABLET 60S, with a completion date of July 12, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $35,321.61 and covers the delivery of 4564676050 - JAKAFI 15 MG TABLET 60S, a specialized pharmaceutical product, with a period of performance through May 22, 2024. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,849.81 contract is for the delivery of JAKAFI 5 MG TABLET 60S, a specialized pharmaceutical product. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which enables the DLA to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,849.81 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order contract, which is not associated with any set-aside designation, is for the provision of JAKAFI 5 MG TABLET 60S, with a period of performance through November 21, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $12,146.79 contract is for the delivery of JAKAFI 5 MG TABLET 60S, a specialized prescription medication, with a completion date of February 6, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of JAKAFI 10 MG TABLET 60S, a specialized prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,807.43, is for the supply of the pharmaceutical product JAKAFI 25 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, valued at up to...
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program. The...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,794.12, is for the delivery of JAKAFI 20 MG TABLET 60S, a specialized pharmaceutical product. The delivery order was awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $48,462.60, is for the delivery of 4567394054 - JAKAFI 10 MG TABLET 60S, a pharmaceutical product, with a completion date of February 27, 2025. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
  • SPE2DB22D9112
    Indefinite Delivery Contract
  • SPE2DB22D9112-SPE2DB25FTKKH
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $12,146.79, is for the delivery of JAKAFI 5 MG TABLET 60S, a specialized pharmaceutical product.

DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This specific delivery order is not associated with a set-aside designation.

Generated 6/5/25, 10:27 AM